Acrivon Therapeutics, Inc. Common Stock
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Acrivon Therapeutics, Inc. Common Stock's balance sheet done over the years? Its assets were worth $138,265,000 last year, which is less than in the previous period. 12% of Acrivon Therapeutics, Inc. Common Stock’s total assets is currently financed by debt. Its liabilities reached the amount of $17,070,000, which means an increase by 59% compared compared to last year.
Debt to Assets
| 2020 | 2185000 | 10.59M | 485.03% |
|---|---|---|---|
| 2021 | 106587000 | 130.39M | 122.34% |
| 2022 | 181226000 | 10.75M | 5.93% |
| 2023 | 138265000 | 17.07M | 12.35% |
ACRV Balance Sheet (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Assets | ||||
Current assets: | ||||
Cash and cash equivalents | 36.01M | 29.51M | 99.60M | 1.58M |
Short term investments | 91.44M | 98.23M | 0 | 0 |
Net receivables | 0 | 0 | 0 | 0 |
Inventory | 0 | 0 | 0 | 0 |
Other current assets | 2.23M | 4.34M | 805K | 136K |
Total current assets | 129.69M | 127.75M | 100.40M | 1.71M |
Non-current assets: | ||||
Property, Plant and Equipment | 7.90M | 6.86M | 5.79M | 59K |
Goodwill | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 |
Long term investments | 414K | 41.88M | 388K | 407K |
Other non-current assets | 251K | 4.73M | 0 | 0 |
Total non-current assets | 8.57M | 53.47M | 6.17M | 466K |
Total assets | 138.26M | 181.22M | 106.58M | 2.18M |
Liabilities | ||||
| Current liabilities: | ||||
Accounts payable | ||||
Deferred revenue | 0 | 69K | 66K | 0 |
Short term debt | 1.75M | 726K | 664K | 58K |
Total current liabilities | 13.30M | 6.51M | 2.91M | 613K |
| Non-current liabilities: | ||||
Long term debt | 3.76M | 4.23M | 4.96M | 9.98M |
Deferred tax | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 0 | 122.51M | 0 |
Total non-current liabilities | 3.76M | 4.23M | 127.48M | 9.98M |
Total liabilities | 17.07M | 10.75M | 130.39M | 10.59M |
| Data source | Data source |